Pacific Biosciences of California PACB Acquired Intangible Amortization
Acquired Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept pacb:AmortizationOfAcquiredIntangibleAssets.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's acquired intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's acquired intangible amortization?
- Pacific Biosciences of California (PACB) reported acquired intangible amortization of $833K in Q1 2026.
- How has Pacific Biosciences of California's acquired intangible amortization changed year-over-year?
- Pacific Biosciences of California's acquired intangible amortization decreased by 99.8% year-over-year, from $362.04M to $833K.
- What is the long-term trend for Pacific Biosciences of California's acquired intangible amortization?
- Over 2 years (2023 to 2025), Pacific Biosciences of California's acquired intangible amortization has grown at a 669.5% compound annual growth rate (CAGR), from $6.16M to $364.54M.
- What does acquired intangible amortization mean?
- This reflects the non-cash expense related to the amortization of intangible assets, such as customer relationships, trademarks, or non-compete agreements, acquired through business combinations. Unlike cost of revenue amortization, these are typically classified as operating expenses. It is a key metric for evaluating the long-term impact of acquisition-related intangible assets on operating profitability.